Kodiak Sciences Inc. (KOD) Discusses DAYBREAK Topline Data and Primary Endpoint Results Transcript
Kodiak Sciences Inc. (KOD) Discusses DAYBREAK Topline Data and Primary Endpoint Results September 28, 2026 8:30 AM EDT
Company Participants
Victor Perlroth – Co-Founder, Chairman, CEO & President
J. Velazquez-Martin – Chief Medical Officer
Conference Call Participants
Charles C. Wykoff
David Brown
Anupam Rama – JPMorgan Chase & Co, Research Division
Umer Raffat – Evercore ISI Institutional Equities, Research Division
Michael Yee – UBS Investment Bank, Research Division
Presentation
Operator
Thank you for standing by, and welcome to Kodiak Sciences DAYBREAK webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. Now it’s my pleasure to turn the call to Victor Perlroth, Chief Executive Officer. Please proceed.
Victor Perlroth
Co-Founder, Chairman, CEO & President
Thank you for joining the Kodiak Sciences DAYBREAK Topline Data Results Conference Call. I’m Victor Perlroth, Kodiak’s Chairman and CEO. The webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so on the Investor Relations section of the Kodiak website. An archive of the webcast will be available on our website.
Let’s turn to Slide #2. I would also like to remind you that remarks made on this call today include forward-looking statements about Kodiak. A more complete description of these and other material risks can be found in Kodiak’s filings with the Securities and Exchange Commission, including its Form 10-Q for the quarterly period ended September — June 30, 2026, which has been filed with the SEC.
Kodiak does not undertake any obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Turning to Slide #3. It’s with pleasure that I welcome all of you to our DAYBREAK primary endpoint results webcast.
